"DCM: LV dilation, reduced ejection fraction, functional mitral regurgitation"
"HCM: asymmetric septal hypertrophy, systolic anterior motion (SAM) of the mitral valve, LVOT obstruction"
"RCM: bi-atrial enlargement, normal wall thickness and systolic function, restrictive filling pattern on Doppler"
"ARVC: RV dilation, RV aneurysms, RV systolic dysfunction"
"DCM: assesses fibrosis with late gadolinium enhancement (LGE), which has prognostic value"
"HCM: precisely measures hypertrophy and detects scar/fibrosis"
"RCM: critical for identifying specific causes like cardiac amyloidosis (diffuse subendocardial LGE) or haemochromatosis (T2* mapping for iron overload)"
"ARVC: excellent for evaluating RV structure, function, and detecting intramyocardial fat/fibrosis"
"aetiological classification (AHA, 2006) 3"
"Status of functional disease severity (NYHA/ACC stage)"
"Status of functional disease severity (NYHA/ACC stage)"
"ARVC: RV dilation, RV aneurysms, RV systolic dysfunction"
"ARVC: RV dilation, RV aneurysms, RV systolic dysfunction"
"ARVC: RV dilation, RV aneurysms, RV systolic dysfunction"
"ARVC: excellent for evaluating RV structure, function, and detecting intramyocardial fat/fibrosis"
"Management is tailored to the specific type and includes heart failure medications (e.g. ACE inhibitors, beta-blockers), arrhythmia management (antiarrhythmics, ICDs), lifestyle modifications, and in advanced cases, heart transplantation."
"Organ involvement"
"Genetic inheritance pattern"
"Etiological annotation"
"Status of functional disease severity (NYHA/ACC stage)"
Expected headings
"Classification"
"characterised by unexplained left ventricular hypertrophy, often with a non-dilated chamber; can be obstructive or non-obstructive"
"largely confined to the heart (e.g. genetic, mixed like DCM, acquired like myocarditis)"
"myocardial involvement as part of a systemic disorder (e.g. amyloidosis, sarcoidosis)"
"Morphofunctional phenotype (e.g. DCM, HCM)"
"Imaging is crucial for diagnosing the phenotype, assessing severity, monitoring progression, and sometimes for suggesting an aetiology (e.g. iron overload, amyloidosis)."
"Management is tailored to the specific type and includes heart failure medications (e.g. ACE inhibitors, beta-blockers), arrhythmia management (antiarrhythmics, ICDs), lifestyle modifications, and in advanced cases, heart transplantation."